Publicaties

Hieronder vindt u alle publicaties vanaf 2004

Publicaties 2011

  1. Schippers JM, Lomax AJ. Emerging technologies in proton therapy. Acta Oncol. 2011 Aug;50(6):838-50. (IF: 3.137, Q2)
     
  2. van Hezewijk M, Ranke GM, van Nes JG, Stiggelbout AM, de Bock GH, van de Velde CJ. Patients' needs and preferences in routine follow-up for early breast cancer; an evaluation of the changing role of the nurse practitioner. Eur J Surg Oncol. 2011 Jul 15. [Epub ahead of print]. (IF: geen).
     
  3. Hadji P, Asmar L, van Nes JG, Menschik T, Hasenburg A, Kuck J, Nortier JW, van de Velde CJ, Jones SE, Ziller M. The effect of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis of the US, German, Netherlands, and Belgium sub-studies. J Cancer Res Clin Oncol. 2011 Jun;137(6):1015-25. (IF: 2.485, Q3).
     
  4. Godart J, Korevaar EW, Visser R, Wauben DJL, van ’t Veld AA. Reconstruction of high resolution 3D dose from matrix measurements: error detection capability of the COMPASS correction kernel method. Phys Med Biol. 2011 Aug 7;56(15):5029-43.). (IF: 3.056; Q1)
     
  5. Creutzberg CL, Nout RA, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras E, van de Poll-Franse LV, van Putten WL; PORTEC study group. Fifteen-Year Radiotherapy Outcomes of the Randomized PORTEC-1 Trial for Endometrial Carcinoma. Int J Radiat Oncol Biol Phys. 2011 Jun 1. [Epub ahead of print]. (IF: 4.503, Q1)
     
  6. Nanduri LSY, Maimets M, Pringle SA, van der Zwaag M, van Os RP, Coppes RP. Regeneration of irradiated salivary glands with stem cell marker expressing cells. Radioth Oncol 2011 Jun;99(3):367-72. (IF: 4.337, Q1)
     
  7. Christianen MEMC, Langendijk JA, van de Water TA, Westerlaan HE, Bijl HP. Delineation guidelines for organs at risk involved in radiation-induced dysphagia. Radioth Oncol 2011 Jun 9 [Epub ahead of print]. (IF: 4.337, Q1)
     
  8. Ramaekers B.L, Joore M.A., Grutters J.P., Van den Ende P., De Jong J., Houben R., Lambin Ph., Christianen M.E.. BeetzI., Pijls-Johannesma M. and Langendijk J.A. The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy. Oral Oncol 2011 Aug;47(8):768-74.(IF: 2.871, Q1)
     
  9. van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA. Using a reduced spot size for intensity modulated proton therapy potentially improves salivary gland sparing in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011 Jun 25 [Epub ahead of print]. (IF: 4.503, Q1)
     
  10. Widder J, Postmus D, Ubbels JF, Wiegman EM, Langendijk JA.  Survival and quality-of-Lifeafter stereotactic body radiotherapy or conventional 3D-radiotherapy for inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys 2011 June 1 [Epub ahead of print].
     
  11. Bantema-Joppe EJ, van der Laan HP, de Bock GH, Wijsman R, Dolsma WV, Busz DM, Langendijk JA, Maduro JH. Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy; first results on local control and survival. Radioth Oncol 2011 June 1 [Epub ahead of print].
     
  12. Beetz I, Schilstra C, Burlage FR, Koken PW, Doornaert P, Bijl HP, Chouvalova O, Leemans CR, de Bock GH, Christianen ME, van der Laan BF, Vissink A, Steenbakkers RH, Langendijk JA. Development of a NTCP model and nomogram in head and neck cancer patients for xerostomia and sticky saliva: the role of the minor salivary glands.Radioth Oncol. 2011 May 30 [Epub ahead of print].
     
  13. Coppes RP, Muijs CT, Faber H, Gross S, Schippers JM, Brandenburg S, Langendijk JA, van Luijk P. Volume dependent expression of in and out of field effects in the proton irradiated rat lung. Int J Radiat Oncol Biol Phys Int J Radiat Oncol Biol Phys 2011 May 21. [Epub ahead of print].
     
  14. Bantema-Joppe EJ, de Munck L, Schaapveld M, Visser O, Willemse PA, Langendijk JA, Siesling S, Maduro JH. Young breast cancer patients with early stage disease: Impact of choice of local treatment on survival. Int J Radiat Oncol Biol Phys 2011 May 19. [Epub ahead of print].
     
  15. Bourhis J, Blanchard P, Maillard E, Brizel D, Movsas B, Buentzel J, Langendijk JA, Komaki R, Leong SS, Levendag P, Pignon JP, on behalf of the MAART Collaborative Group. Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. J Clin Oncol 2011 May 16. [Epub ahead of print]. (IF: 17.793, Q1)
     
  16. van Hoesel AQ, van de Velde CJ, Kuppen PJ, Putter H, de Kruijf EM, van Nes JG, Giuliano AE, Hoon DS. Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer. Breast Cancer Res Treat. 2011 Apr 11. (IF: 4.696, Q1).
     
  17. Boomsma-van Holten, Bijl HP, Langendijk JA. Radiation-induced hypothyroidism in head and neck cancer patients: a review of literature. Radioth Oncol [Epub ahead of print]. (06-04-2011).(IF: 4.343, Q1)
     
  18. van de Water TA, Bijl HP, Schilstra C, Pijls-Johannesma M, Langendijk JA. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue-sparing: A systematic review of literature.Oncologist. 2011;16(3):366-77 (IF: 6.701, Q1).
     
  19. Van Abbema JK, van der Schaaf A, Kristanto W, Groen JM, Greuter MJ. Feasibility and accuracy of tissue characterization with dual source computed tomography. Phys Med. 2011 Feb 16. [Epub ahead of print]. (IF: 1.045, Q4 (malusartikel)).
     
  20. van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug E, Langendijk JA. Potential benefits of scanned intensity modulated proton therapy (IMPT) versus intensity modulated radiotherapy with photons (IMRT) with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1216-24.  (IF: 4.592, Q1).
     
  21. Ramaekers B, Pijls-Johannesma M, Grutters J, van den Ende PLE, Lambin P, Kessels A, Joore M, Langendijk JA. Systematic review and meta-analyses ofproton, carbon-ion and photon radiotherapy in head and neck cancer. Cancer Treat Rev. 2011 May;37(3):185-201. (IF: 5.295, Q1).
     
  22. van Goethem MJ, Niemantsverdriet M, Brandenburg S, Langendijk JA, Coppes RP, van Luijk P. Development of a setup for high-precision irradiation of cells with carbon ions. Med Phys. 2011 Jan;38(1):256-63. (IF: 2.704, Q2).
     
  23. Pringle S, Nanduri LS, van der Zwaag M, van Os R, Coppes RP. Isolation of mouse salivary gland stem cells. J Vis Exp. 2011 Feb 8;(48) (no IF).
     
  24. Agool A, Slart RH, Thorp KK, Glaudemans AW, Cobben DC, Been LB, Burlage FR, Elsinga PH, Dierckx RA, Vellenga E, Holter JL. Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study. Nucl Med Commun. 2011 Jan; 32(1):17-22. (IF: 1.315, Q3).
     
  25. Brummelman P, Elderson MF, Dullaart RP, van den Bergh AC, Timmer CA, van den Berg G, Koerts J, Tucha O, Wolffenbuttel BH, Van Beek AP. Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol (Oxf). 2010 Dec 6. [Epub ahead of print].(IF: 3.201, Q2>30).
     
  26. Coppes RP, Stokman MA. Stem cells and the repair of radiation-induced salivary gland damage. Oral Diseases 2011 Mar 17(2):143-53. (IF: 1.922, Q2n).
     
  27. de Kruijf EM, van Nes JG, van de Velde CJ, Putter H, Smit VT, Liefers GJ, Kuppen PJ, Tollenaar RA, Mesker WE. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat. 2011 Feb;125(3):687-96. Epub 2010 Apr 2. (IF: 4.696, Q1).
     
  28. Elferink MA, Siesling S, Lemmens VE, Visser O, Rutten RJ, van Krieken JH, Tollenaar RA, Langendijk JA. Variation in lymph node evaluation in rectal cancer: A Dutch nationwide population-based study. Ann Surg Oncol. 2011 Feb;18(2):386-95 (IF: 4.130, Q1).
     
  29. Ferlito A,Robbins KT, Shah JP, Medina JE, Silver CE, Al-Tamimi S, Fagan JJ, Paleri V, Takes RP, Bradford CR, Devaney KO,Stoeckli SJ, Weber RS, Bradley PJ, Suárez C, Leemans CR, Coskun HH,  Pitman KT, Shaha AR, de Bree R, Hartl dm, Haigentz Jr M, Rodrigo JP, Hamoir M, Khafif A, Langendijk JA, Owen RP, Sanabria A, Strojan P, van der Poorten V, Werner JA, BieńS, Woolgar JA, Zbären P, Betka J, Folz BJ, Genden EM, Talmi YP, Strome M, Herranz González Botas J, Olofsson J, Kowalski LP, Holmes JD, Hisa Y, Rinaldo A. A Proposal for a Rational Classification of Neck Dissections Head Neck.Head Neck. 2011 Mar;33(3):445-50 (IF: 2.283, Q1).
     
  30. Hartl DM, Ferlito A, Brasnu DF, Rinaldo A, Langendijk JA, Silver CE, Wolf GT. Evidence Based Review of Organ Preserving  Treatment Options for Patients with Glottic Cancer. Head Neck. 2011 Jan 6. [Epub ahead of print](IF: 2.283, Q1).
     
  31. Hurkmans CW, van Lieshout M, Schuring D, van Heumen MJ, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide UA, Senan S. Quality Assurance of 4D-CT Scan Techniques in Multicenter Phase III Trial of Surgery Versus Stereotactic Radiotherapy (Radiosurgery Or Surgery for operable Early stage (Stage 1A) non-small-cell Lung cancer [ROSEL] Study). Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):918-27. (IF: 4.592, Q1).
     
  32. Jager-Wittenaar H, Dijkstra PU, Vissink A, Langendijk JA, van der Laan BFAM, Pruim J, Roodenburg JLN. Changes in nutritional status and dietary intake during and after head and neck cancer treatment.Head Neck 2010 Aug 24.[Epub ahead of print]. (IF: 2.283, Q1).
     
  33. Janssens GO, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Pop LA, Kaanders JH. Acute Toxicity Profile and Compliance to Accelerated Radiotherapy Plus Carbogen and Nicotinamide for Clinical Stage T2-4 Laryngeal Cancer: Results of a Phase III Randomized Trial. Int J Radiat Oncol Biol Phys. 2011 Feb 5. [Epub ahead of print]. (IF: 4.592, Q1).
     
  34. Korfage A, Schoen PJ, Raghoebar GM, Bouma J, Burlage FR, Roodenburg JL, Vissink A, Reintsema H. Five-year follow-up of oral functioning and quality of life in patients with oral cancer with implant-retained mandibular overdentures. Head Neck. 2010 Dec 9. [Epub ahead of print]. (IF: 2.283, Q1).
     
  35. Muijs CT, Beukema JC, Pruim J, Havenga K, Widder J, van den Bergh ACM, Langendijk JA. Short communication: 18F-FLT-PET for detection of rectal cancer; a pilot study (1st version: 18-10-2009).Radiother Oncol. 2011 Mar;98(3):357-9.(IF: 4.343, Q1)
     
  36. Noordhuis MG, Eijsink JJ, Roossink F, de Graeff P, Pras E, Schuuring E, Wisman GB, de Bock GH, van der Zee AG. Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: a systematic review. Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):325-34. Review. (IF: 4.592, Q1).
     
  37. Peters TTA, van der Laan BFAM, Plaat BEC, Wedman J, Roodenburg J, Langendijk JA, Halmos GB. Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: a matched control study. Oral Oncol. 2011 Jan;47(1):56-61.(IF: 3.123, Q1).
     
  38. Robbins, KT, Ferlito A, Silver C, Takes R, Strojan P, Snyderman C, de Bree R, Haigentz M, Langendijk JA, Rinaldo A, Shaha A, Hanna E, Werner J, Suarez C. Management of Sinonasal Cancer. Head and Neck 2010 Aug;24 [Epub ahead of print]. (IF: 2.283, Q1).
     
  39. Spizzo G, Ofner D, de Vries A, Lukas P, Steger G, Pluschnig U, Zacherl J, Widder J, Zabernigg A, Gastl G, Mühlmann G. Preoperative Chemotherapy with Cisplatin and Docetaxel Followed by Surgery and Clip-Oriented Postoperative Chemoradiation in Patients with Localized Gastric or Gastroesophageal Junction Adenocarcinoma: Results from a Phase II Feasibility Study. 2011 Mar;18(3):677-83. (IF: 4.133, Q1).
     
  40. Strojan P, Ferlito A, Langendijk JA, Silver CE. Indications for radiotherapy after neck dissection. Head Neck. 2010 Nov 10. [Epub ahead of print] (IF: 2.283, Q1).
     
  41. Takes R, Strojan P, Silver C, Bradley P, Haigentz M, Wolf G, Shaha A, Hartl D, Olofsson J, Langendijk JA, Ferlito A. Current Trends in Initial Management of Hypopharyngeal Cancer: the Declining Use of Open Surgery. Head Neck. 2010 Nov 10. [Epub ahead of print](IF: 2.283, Q1).
     
  42. Talmi YP, Ferlito A, Takes RP, Strojan P, Langendijk JA, Shaha AR. Lymph node metastasis in nasal vestibule cancer: a review. Head Neck. 2010 Dec 9. [Epub ahead of print].(IF: 2.283, Q1).
     
  43. van den Bergh ACM, Pruim J, Links T, van der Vliet AM, Sluiter W, Wolffenbuttel BHR, Langendijk JA, Hoving EW, Dullaart RPF. Tyrosine Positron Emission Tomography and protein synthesis rate in pituitary adenoma: different effects of surgery and radiation therapy. Radiother Oncol. 2011 Feb 4. [Epub ahead of print]. (IF: 4.343, Q1)
     
  44. van Nes JG, de Kruijf EM, Faratian D, van de Velde CJ, Putter H, Falconer C,Smit VT, Kay C, van de Vijver MJ, Kuppen PJ, Bartlett JM. COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients. Breast Cancer Res Treat. 2011 Feb;125(3):671-85. Epub 2010 Apr 1. (IF: 4.696, Q1).
     
  45. van Scheppingen C, Schroevers MJ, Smink A, van der Linden YM, Mul VE, Langendijk JA, Coyne JC, Sanderman R. Does screening for distress efficiently uncover meetable unmet needs in cancer patients? Psychooncology. 2011 Mar 6. doi: 10.1002/pon.1939. [Epub ahead of print]
     
  46. Vergeer MR, Doornaert PAH, de Bree R, Leemans CR, Slotman BJ, Langendijk JA. Postoperative elective nodal irradiation for squamous cell carcinoma of the head and neck: outcome and prognostic factors for regional recurrence. Ann Oncol. 2011 Mar 1. [Epub ahead of print] (IF: 5.647, Q1).
     
  47. Wiegman EM, Widder J, Ubbels JF, Pruim J, Langendijk JA. Prediction of treatment outcome using 18F-FDG-PET during stereotactic body radiotherapy for FDG-PET staged early non-small cell lung cancer: A pilot study. Eur J Nucl Med Mol Imaging. 2011 Jan 6. [Epub ahead of print] (IF: 4.531, Q1). 

 Publicaties 2010

  1. Agool A, Slart RH, Thorp KK, Glaudemans AW, Cobben DC, Been LB, Burlage FR, Elsinga PH, Dierckx RA, Vellenga E, Holter JL. Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study. Nucl Med Commun. 2010 Dec 6. [Epub ahead of print].(IF: 1.315, Q3).
     
  2. Beetz I, Burlage FR, Bijl HP, Hoegen-Chouvalova O, Christianen MEMC, Vissink A, van der Laan BFAM, de Bock GH, Langendijk JA. The Groningen Radiotherapy-induced xerostomia questionaire; development and validation of a new questionnaire. Radiother Oncol. 2010 Oct;97(1):127-31. (IF: 4.343, Q1)
     
  3. Bijen CB, Bantema-Joppe EJ, de Jong RA, Leffers N, Mourits MJ, Eggink HF, van der Zee AG, Hollema H, de Bock GH, Nijman HW. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.Int J Cancer. 2010 Mar 15;126(6):1417-27. (IF: 4.722, Q1)
     
  4. Breeuwsma AJ, Pruim J, van den Bergh ACM, Leliveld AM, Nijman RJM, Dierckx RA, de Jong IJ. Detectionof Local, Regional and Distant Recurrence in Patients with PSA Relapse after External Beam Radiotherapy using 11C-Choline Positron Emission Tomography (PET). Int J Radiat Oncol Biol Phys 2010;77(1):160-4. (IF: 4.592, Q1)
     
  5. Brummelman P, Elderson MF, Dullaart RP, van den Bergh AC, Timmer CA, van den Berg G, Koerts J, Tucha O, Wolffenbuttel BH, Van Beek AP. Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy.Clin Endocrinol (Oxf). 2010 Dec 6. [Epub ahead of print].(IF: 3.201, Q2>30).
     
  6. Coppes RP, Stokman MA. Stem cells and the repair of radiation-induced salivary gland damage. Oral Diseases 2010 Sep 1.[Epub ahead of print]. (IF: 1.922, Q2n).
     
  7. De Jong IJ, De Haan TD, Wiegman EM, Van Den Bergh AC, Pruim J, Breeuwsma AJ. PET/CT and radiotherapy in prostate cancer.Q J Nucl Med Mol Imaging. 2010 Oct;54(5):543-52. (IF: 2.877, Q1).
     
  8. de Jong JS, Beukema JC, van Dam GM, Slart R, Lemstra C, Wiggers T. Limited value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: a prospective study with long-term follow-up. Ann Surg Oncol. 2010 Oct;17(10):2656-62. (IF: 4.133, Q1)
     
  9. de Jong JS, Beukema JC, van Dam GM, Slart R, Lemstra C, Wiggers T. Limited Value of Staging Squamous Cell Carcinoma of the Anal Margin and Canal Using the Sentinel Lymph Node Procedure: A Prospective Study with Long-Term Follow-Up. Ann Surg Oncol. 2010 Oct;17(10):2656-62.(IF: 4.130, Q1)
     
  10. Eikmans H, Hoving EW, Meiners LC, van der Horstschrivers A, Bijl HP, Links TP. Eight plus years survival after diagnosis of multiple brain metastases from follicular thyroid carcinoma.Thyroid. 2010 Jun;20(6):663-4. (IF: 2.602, Q3)
     
  11. Elferink MAG, Krijnen P, Wouters MW, Lemmens VE, Jansen-Landheer ML, van de Velde CJ,  Langendijk JA, Marijnen CAM, Siesling S, Tollenaar. RA. Variation in treatment and outcome in patients with rectal cancer care by region and hospital type and volume in the Netherlands. Eur J Surg Oncol. 2010 Sep;36 Suppl 1:S74-82. (IF: 4.130, Q1).
     
  12. Erlferink MA, Siesling S, Lemmens VE, Visser O, Rutten RJ, van Krieken JH, Tollenaar RA, Langendijk JA. Variation in lymph node evaluation in rectal cancer: A Dutch nationwide population-based study. Ann Surg Oncol 2010 Aug;24 [Epub ahead of print]. (IF: 4.130, Q1).
     
  13. Ferlito A,Robbins KT, Shah JP, Medina JE, Silver CE, Al-Tamimi S, Fagan JJ, Paleri V, Takes RP, Bradford CR, Devaney KO,Stoeckli SJ, Weber RS, Bradley PJ, Suárez C, Leemans CR, Coskun HH,  Pitman KT, Shaha AR, de Bree R, Hartl dm, Haigentz Jr M, Rodrigo JP, Hamoir M, Khafif A, Langendijk JA, Owen RP, Sanabria A, Strojan P, van der Poorten V, Werner JA, BieńS, Woolgar JA, Zbären P, Betka J, Folz BJ, Genden EM, Talmi YP, Strome M, Herranz González Botas J, Olofsson J,  Kowalski LP, Holmes JD, Hisa Y, Rinaldo A. A  Proposal for a Rational Classification of Neck Dissections Head Neck.Head Neck. 2010 Nov 10. [Epub ahead of print] (IF: 2.283, Q1).
     
  14. Fromm-Haidenberger S, Pohl G, Widder J, Kren G, Fitzal F, Bartsch R, de Vries J, Zielinski C, Pötter R. Vienna International Summer School on Experimental and Clinical Oncology for Medical Students: An Austrian Cancer Education Project. J Cancer Educ. 2010 Mar;25(1):51-4. (IF: 0.520, Q4)
     
  15. Ghobadi G, Hogeweg LE, Faber H, Tukker WGJ, Schippers JM, Brandenburg S, Langendijk JA, Coppes RP, van Luijk P. Quantifying local radiation-induced lung damage from computed tomography. Int J Radiat Oncol Biol Phys 2010; 76(2): 548-556. (IF: 4.592, Q1)
     
  16. Gross S, Homan van der Heide JJ, van Son WJ, Gans RO, Foell D, Navis G, Bakker SJ. Body mass index and creatinine clearance are associated with steady-state serum concentrations of the cell damage marker S100B in renal transplant recipients. Med Sci Monit. 2010;16(7):CR318-24.
     
  17. Grutters JPC, Joore MA, Wiegman EM, Langendijk JA, De Ruysscher D, Hochstenbag M, Botterweck A, Lambin P, Pijls-Johannesma M. Health-related quality of life in patients surviving non-small cell lung cancer. Thorax. 2010 Oct;65(10):903-7. (IF: 7.041, Q1).
     
  18. Houweling AC, Philippens ME, Dijkema T, Roesink JM, Terhaard CH, Schilstra C, Ten HakenRK, Eisbruch A, Raaijmakers CP. A Comparison of Dose-response Models for the Parotid Gland in a Large Group of Head-and-neck Cancer Patients. Int J Radiat Oncol Biol Phys 2010 Mar 15;76(4):1259-65. (IF: 4.592, Q1)
  19. Hurkmans CW, van Lieshout M, Schuring D, van Heumen MJ, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide UA, Senan S. Quality Assurance of 4D-CT Scan Techniques in Multicenter Phase III Trial of Surgery Versus Stereotactic Radiotherapy (Radiosurgery Or Surgery for operable Early stage (Stage 1A) non-small-cell Lung cancer [ROSEL] Study). Int J Radiat Oncol Biol Phys. 2010 Oct. (IF: 4.592, Q1).
     
  20. Jager-Wittenaar H, Dijkstra PU, Vissink A, Langendijk JA, van der Laan BFAM, Pruim J, Roodenburg JLN. Changes innutritional status and dietary intake during and after head and neck cancer treatment. Head Neck2010 Aug 24.[Epub ahead of print]. (IF: 2.283, Q1).
     
  21. Janssen MHM, Aerts HJWL, Kierkels RGJ, Backes WH, Ollers MC, Buijsen J, Lambin P, Lammering G. Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: Sequential perfusion-CT findings. Radiother Oncol 2010; 94(2): 156-160.
     
  22. Korfage A, Schoen PJ, Raghoebar GM, Bouma J, Burlage FR, Roodenburg JL, Vissink A, Reintsema H. Five-year follow-up of oral functioning and quality of life in patients with oral cancer with implant-retained mandibular overdentures. Head Neck. 2010 Dec 9. [Epub ahead of print]. (IF: 2.283, Q1).
     
  23. Langendijk JA, Ferlito A, Takes RP, Rodrigo JP, Suarez J, Strojan P, Haigentz M, Rinaldo AJ. Postoperative strategies after curative surgery for squamous cell carcinoma of the head and neck. Review. Oral Oncol. 2010 Aug;46(8):577-85. (IF: 3.123, Q1)
     
  24. Langendijk JA, Psyrri A.The prognostic significance of p16 over-expression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies. Ann Oncol. 2010 Oct;21(10):1931-4.(IF: 5.647, Q1).Editorial.
     
  25. Langius JAE, Doornaert PAH, Spreeuwenberg MD, Langendijk JA, Leemans CR, Bokhorst-de van der Schueren MAE. Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer. Radiother Oncol. 2010 Oct;97(1):80-5. (IF: 4.343, Q1)
     
  26. Maduro JH, den Dekker HA, Pras E, de Vries EG, van der Zee AG,Klokman WJ, Reyners AK, van Leeuwen FE,Langendijk JA,de Bock GH,Gietema JA. Cardiovascular morbidity after radiotherapy or chemoradiation in patients with cervical cancer.Int J Radiat Oncol Biol Phys 2010 Dec 1;78(5):1337-44. (IF: 4.592, Q1)
     
  27. Martens HA, Gross S, van der Steege G, Brouwer E, Berden JH, de Sevaux R, Derksen RH, Voskuyl AE, Berger SP, Navis GJ, Kallenberg CG, Bijl M. Lack of association of C-C chemokine receptor 5Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.J Rheumatol. 2010 Nov;37(11):2226-31.
     
  28. Matzinger O, Heimsoth I, Poortmans P, Collette L, Struikmans H, Van Den Bogaert W, Fourquet A, Bartelink H, Ataman F, Gulyban A, Pierart M, Van Tienhoven G, Poortmans PH, Van Den Bogaert W, Kirkove C, Budach VG, Maingon P, Carla Valli M, Immerzeel JJ, Warlam-Rodenhuis C, Le Pechoux C, Bamberg M, Van Tienhoven G, Glanzmann C, Lutolf UM, Fourquet A, Kuten A, Quetin P, Baeza R, David M, Jobsen J, Sunyach MP, Bartelink H, Russell N, Mirimanoff RO, Bolla M, Beauduin M, Pfeffer R, Lagrange JL, Dilhuydy JM, Chenal, Benchalal M, Huget P, Courdi A, Bosset JF, Kobierska A, Senkus-Konefka E, Kurtz J, Balmer-Majno S, Koswig S, Krebs H, Bongartz R, Struikmans H, Amalric F, Dolsma WV, Jager JJ, Stellamans K, Guenzi M, Stuschke M, Villa S, Boladeras A, Basic H, Badinez L, Silva I, Muller HM, Strnad V. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol. 2010;49(1):24-34. (IF: 2.265, Q3)
     
  29. Muijs CT, Beukema JC, Pruim J, Mul VE, Groen H, Plukker JTh, Langendijk JA. A critical review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with oesophageal cancer. Radiother Oncol. 2010 Nov;97(2):165-71. (IF: 4.343, Q1)
     
  30. Niemantsverdriet M, de Jong E, Langendijk JA, Kampinga HH, Coppes RP. Synergistic induction of profibrotic PAI-1 by TGF-band radiation depends on p53. Radiother Oncol. 2010 Oct;97(1):33-5.(IF: 4.343, Q1)
     
  31. Oskam IM, Verdonck-de Leeuw IM, Aaronson NK, Kuik DJ, de Bree R, Doornaert PAH, Langendijk JA, Leemans ChR. Health related quality of life as predictor of survival in patients after surgical treatment for advanced oral and oropharyngeal cancer. Radioth Oncol 2010 Nov;97(2):258-62.(IF: 4.343, Q1)
     
  32. Pattje WJ, Schuuring E, Mastik MF, Slagter-Menkema L, Schrijvers ML,Alessi S, van der LaanBFAM, Roodenburg JJ, Langendijk JA, van der Wal JE. PTEN mediates radio-sensitivity in head and neck cancer. Br J Cancer 2010; 102(12): 1778-85. (IF: 4.346, Q1)
     
  33. Peters TTA, van der Laan BFAM, Plaat BEC, Wedman J, Roodenburg J, Langendijk JA, Halmos GB. Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: a matched control study. Oral Oncology 2010 Nov 24 [Epub ahead of print]. (IF: 3.123, Q1)
     
  34. Psyrri A, Licitra L, Lacombe D, Schuuring E,Budach W, Ozsahin M,Knecht R, Vermorken JB, Langendijk JA. Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: A Report from the Translational Research Subcommittee. Ann Oncol. 2010 Oct;21(10):1952-60.(IF: 5.647, Q1)
     
  35. Ramaekers B, Pijls-Johannesma M, Grutters J, van den Ende PLE, Lambin P, Kessels A, Joore M, Langendijk JA. Systematic review and meta-analyses of proton, carbon-ion and photon radiotherapy in head and neck cancer. Cancer Treat Rev 2010 Sep 1. [Epub ahead of print]. (IF: 5.295, Q1).
     
  36. Rasch CR, Steenbakkers RJ, Fitton I, Duppen JC, Nowak PJ, Pameijer FA, Eisbruch A, Kaanders JM, Paulsen F, Herk MV. Decreased 3D observer variation with matched CT- MRI, for target delineation in Nasopharynx cancer. Radiat Oncol. 2010 Mar 15;5(1):21. (IF: 2.529, Q2)
     
  37. Robbins, KT, Ferlito A, Silver C, Takes R, Strojan P, Snyderman C, de Bree R, Haigentz M, Langendijk JA, Rinaldo A, Shaha A, Hanna E, Werner J, Suarez C. Management of Sinonasal Cancer. Head and Neck 2010 Aug;24 [Epub ahead of print]. (IF: 2.283, Q1).
     
  38. Roelofs E, Persoon L, Qamhiyeh S, Verhaegen F, De Ruysscher D, Scholtz M, Iancu G, Engelsman M, Rasch C,Zijp L, De Meerleer G,Coghe M, Langendijk J, Schilstra C, Pijls-Johannesma M, Lambin P. Design and technical challenges of a framework for multicentric radiotherapy treatment planning studies. Radiother Oncol. 2010 Dec;97(3):567-71. (IF: 4.343, Q1)
     
  39. Schreurs LM, Busz DM, Paardekooper GM, Beukema JC, Jager PL, Van der Jagt EJ, van Dam GM, Groen H, Plukker JT, Langendijk JA. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability. Dis Esophagus. 2010 Aug;23(6):493-501. (IF: 1.493, Q3)
     
  40. Spizzo G, Ofner D, de Vries A, Lukas P, Steger G, Pluschnig U, Zacherl J, Widder J, Zabernigg A, Gastl G, Mühlmann G. Preoperative Chemotherapy with Cisplatin and Docetaxel Followed by Surgery and Clip-Oriented Postoperative Chemoradiation in Patients with Localized Gastric or Gastroesophageal Junction Adenocarcinoma: Results from a Phase II Feasibility Study. Ann Surg Oncol. 2010. (IF: 4.133, Q1)
     
  41. Strojan P, Ferlito A, Langendijk JA, Silver CE. Indications for radiotherapy after neck dissection. Head Neck. 2010 Nov 10. [Epub ahead of print] (IF: 2.283, Q1).
     
  42. Suarez C, Rodrigo J, Rinaldo A, Langendijk JA, Shaha A, Ferlito A. Reirradiation versus surgery in recurrent nasopharyngeal carcinoma. Review. Eur Arch Otorhinolaryngol. 2010 Dec;267(12):1811-24. (IF: 1.167, Q3).
     
  43. Takes R, Strojan P, Silver C, Bradley P, Haigentz M, Wolf G, Shaha A, Hartl D, Olofsson J, Langendijk JA, Ferlito A. Current Trends in Initial Management of Hypopharyngeal Cancer: the Declining Use of Open Surgery. Head Neck. 2010 Nov 10. [Epub ahead of print](IF: 2.283, Q1).
     
  44. Talmi YP, Ferlito A, Takes RP, Strojan P, Langendijk JA, Shaha AR. Lymph node metastasis in nasal vestibule cancer: a review. Head Neck. 2010 Dec 9. [Epub ahead of print].(IF: 2.283, Q1).
     
  45. van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug E, Langendijk JA. Potential benefits of scanned intensity modulated proton therapy (IMPT) versus intensity modulated radiotherapy with photons (IMRT) with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2010 Aug 21 [Epub ahead of print]. (IF: 4.592, Q1).
     
  46. van der Laan HP, Dolsma WV, Schilstra C, Korevaar EW, de Bock GH, Maduro JH, Langendijk JA. Limited benefit of inversely optimised intensity modulation in breast conserving radiotherapy with simultaneously integrated boost. Radiother Oncol. 2010 Mar;94(3):307-12. (IF: 4.343, Q1)
     
  47. van der Laan HP, Hurkmans CW, Kuten A, Westenberg HA; On behalf of the EORTC-ROG Breast Working Party.Current technological clinical practise in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions. Radioth Oncol 2010 Mar;94(3):280-285. (IF: 4.343, Q1)
     
  48. van der Laan HP, Korevaar EW, Dolsma WV, Maduro JH, Langendijk JA. Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation. Radioth Oncol 2010 Feb;94(2):235-40. (IF: 4.343, Q1)
     
  49. van der Putten L, de Bree R, Kuik DJ,Rietveld DHF, LangendijkJA, Leemans CR. Hypopharyngeal carcinoma after radiation for tuberculosis: radiation-induced carcinoma. Oral Oncol. 2010 Sep;46(9):672-7.(IF: 3.123, Q1).
     
  50. van Holten MJ, Roesink JM, Terhaard CH, Braam PM. New insights in the vascular irradiation.Head Neck 2010; 2010 Jul;32(7):837-43. (IF: 2.283, Q1).
     
  51. van Mourik AM, Elkhuizen PH, Minkema D, Duppen JC, van Vliet-Vroegindeweij C, Bartelink H, Boersma L, Creutzberg C, Maduro J, Poortmans P, Pomp J, Russell N, van der Sangen M, Schinagl D, Smit W, Steenbakkers R, Stenfert Kroese M, Struikmans H, Tabak J, Westenberg H. Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. Radiother Oncol. 2010 Mar; 94(3):286-91.(IF: 4.343, Q1)
     
  52. Vergeer MR, Doornaert PAH, Jonkman A, Kaanders JHAM, van den Ende PLA, de Jong MA, Leemans CR, Slotman BJ, Langendijk JA. Ipsilateral irradiation for oropharyngeal and oral carcinoma treated with primary surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):682-8. (IF: 4.592, Q1)
     
  53. Vissink A,Mitchel JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, Elting LS, Langendijk JA, Coppes RP, Reyland ME. Clinical management of salivary gland hypofunction and xerostomia in head and neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys 2010 Nov 15;78(4):983-91.(IF: 4.592, Q1).
     
  54. West C, Rosenstein BS, Alsner J, Azria D, Barnett G, Begg A, Bentzen S, Burnet N, Chang-Claude J, Chuang E, Coles C, De Ruyck K, De Ruysscher D, Dunning A, Elliott R, Fachal L, Hall J, Haustermans K, Herskind C, Hoelscher T, Imai T, Iwakawa M, Jones D, Kulich C; EQUAL-ESTRO, Langendijk JA, O'Neils P, Ozsahin M, Parliament M, Polanski A, Rosenstein B, Seminara D, Symonds P, Talbot C, Thierens H, Vega A, West C, Yarnold J. Establishment of a Radiogenomics Consortium. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1295-6. (IF: 4.592, Q1)
     
  55. Widder J, Hollander M, Ubbels JF, Bolt R, Langendijk JA. Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation. Radioth Oncol 2010 Jan; 94(1):42-46. (IF: 4.343, Q1)
     
  56. Coppes RP, Lombaert IMA. Is stem cell therapy a reasonable approach? In: Dry Mouth, The malevolent symptom: A clinical guide. Sreebny LM and Vissink A eds. Wiley-Blackwell Iowa 2010. ISBN 978-0-8183-1623-4
     
  57. Roodenburg JLN, Batenburg de Jong RJ, Reintsema H, van Laer CG, Langendijk JA, Vermeersch H, Vermorken JB. Hoofdhals tumoren. In: Oncologie. Ed: Velde CJH van de, Krieken JHJM van, Mulder PHM de, Vermorken JB. Bohn Stafleu van Loghum. Houten, 2010.
     
  58. de Bree R, Langendijk JA, Leemans CR. Multidisciplinary treatment of the neck. In: Head and Neck Cancer: Multimodality Management. Ed.: Bernier J. 1st Edition. Springer Verlag, New York, 2011.

Publicaties 2009  

  1. Bolla M, De Reijke TM, Van Tienhoven G, Van den Bergh ACM, Oddens J, Poortmans PMP, Gez E, Kil P, Akdas A, Soete G, Kariakine O, van der Steen-Banasik EM, Musat E, Pierart M, Collette L, for the EORTC Radiation Oncology Group and Genito-Urinary Tract Cancer Group. Duration of androgen suppression in the treatment of locally advanced prostate cancer(EORTC 22961). N Engl JMed 2009; 360(24):2516-27.
     
  2. Burlage FR, Faber H, Kampinga HH, Langendijk JA, Vissink A, Coppes RP. Enhanced proliferation of acinar and progenitor cells by prophylactic pilocarpine treatment underlies the observed amelioration of radiation injury to parotid glands. Radiother Oncol. 2009 Feb;90(2):253-6.
     
  3. Buunk AP, Brakel TM, Bennenbroek FTC,Stiegelis HE, Sanderman R, Van den Bergh ACM, Hagedoorn M. Neuroticism and Responses to Social Comparison among Cancer Patients. Eur J Personality 2009; 23(6): 475-487.
     
  4. Coppes RP, van der Goot A, Lombaert IM. Stem cell therapy to reduce radiation-induced normal tissue damage. Semin Radiat Oncol. 2009 Apr;19(2):112-21.
     
  5. Crijns AP, Fehrmann RS, de Jong S, Gerbens F, Meersma GJ, Klip HG, Hollema H, Hofstra RM, te Meerman GJ, de Vries EG, van der Zee AG. Survival-related profile, pathways, and transcription factors in ovarian cancer. PLoS Med. 2009 Feb 3;6(2):e24.
     
  6. de Bruijn MJ, ten Bosch L, Kuik DJ, Quené H, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM. Objective acoustic-phonetic speech analysis in patients treated for oral or oropharyngeal cancer. Folia Phoniatr Logop. 2009;61(3):180-7.
     
  7. de Graeff P, Crijns AP, de Jong S, Boezen M, Post WJ, de Vries EG, van der Zee AG, de Bock GH. Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis. Br J Cancer. 2009 Jul 7;101(1):149-59.
     
  8. Engelen MJ, Snel BJ, Schaapveld M, Pras E, de Vries EG, Gietema JA, van der Zee AG, Willemse PH. Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer. Eur J Cancer. 2009 Feb 6.
     
  9. Feng J, van der Zwaag M, Stokman MA, van Os R, Coppes RP.Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation. Radiother Oncol. 2009 Sep;92(3):466-71.
     
  10. Giro C, Berger B, Bölke E, Ciernik IF, Duprez F, Locati L, Maillard S, Ozsahin M, Pfeffer R, Robertson AG, Langendijk JA, Budach W. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes. Radiother Oncol. 2009 Feb;90(2):166-71.
     
  11. Hartog JWL, Gross S, Oterdoom LH, van Ree RM, de Vries APJ, Smit AJ, Schouten JP, Nawroth PP, Gans ROB, van Son WJ, Bierhaus A, Bakker SJL. Skin-Autofluorescence Is an Independent Predictor of Graft Loss in Renal Transplant Recipients. Transplantation 87(7): 1069-1077, 2009
     
  12. Houweling AC, Philippens ME, Dijkema T, Roesink JM, Terhaard CH, Schilstra C, Ten HakenRK, Eisbruch A, Raaijmakers CP. A Comparison of Dose-response Models for the Parotid Gland in a Large Group of Head-and-neck Cancer Patients. Int J Radiat Oncol Biol Phys 2009; Epub ahead of print.
     
  13. Huang YW, Jansen RA, Fabbri E, Potter D, Liyanarachchi S, Chan MW, Liu JC,Crijns AP, Brown R, Nephew KP, van der Zee AG, Cohn DE, Yan PS, Huang TH, Lin HJ.Identification of candidate epigenetic biomarkers for ovarian cancer detection.Oncol Rep. 2009 Oct;22(4):853-61.
     
  14. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide UA, Schuring  D, Senan S. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et al. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):318; author reply 318.
     
  15. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide UA, Schuring D, Senan S. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol. 2009 Jan 12;4:1.
     
  16. Jongen VH, Briët JM, de Jong RA, Joppe E, ten Hoor KA, Boezen HM, Evans DB, Hollema H, van der Zee AG, Nijman HW. Aromatase, cyclooxygenase 2, HER-2/neu, and p53 as prognostic factors in endometrioid endometrial cancer. Int J GynecolCancer. 2009 May;19(4):670-6.
     
  17. Langendijk JA, Doornaert P, Rietveld DH, Verdonck-de Leeuw IM, René Leemans C, Slotman BJ. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol. 2009 Feb;90(2):189-95.
     
  18. Lefebvre JL, Ang KK, Bardet E, Béatrix B, Bernier J, Bourhis J, Budach V, Calais G, Conley B, Forastiere A, Knecht R, Langendijk JA, Leemans R, Licitra Lisa, Posner M, de Raucourt D, Rolland F,  Temam S, Vermorken JB, Vokes E, Weber R, Wolf G. Larynx preservation clinical trial design: Key issues and recommendations-A consensus panel summary. Head Neck. 2009 Mar 12;31(4):429-441.
     
  19. Maduro JH, Noordhuis MG, ten Hoor KA, Pras E, Arts HJG, Eijsink JJH, Hollema H, Mom CH, de Jong S,  de Vries EGE,  de Bock GH, van der Zee AGJ. The prognostic value of TRAIL and its death receptors in cervical cancer.Int J Radiat Oncol Biol Phys. 2009;75(1):203-11.
     
  20. Matzinger O, Duclos F, van den Bergh A, Carrie C, Villà S, Kitsios P, Poortmans P, Sundar S, van der Steen-Banasik EM, Gulyban A, Collette L, Bolla M; EORTC Radiation Oncology Group. Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. Eur J Cancer. 2009 Nov;45(16):2825-34.
     
  21. Matzinger O, Poortmans P, Giraud JY, Maingon P, Budiharto T, van den Bergh AC, Davis JB, Musat E, Ataman F, Huyskens DP, Gulyban A, Bolla M; for the EORTC Radiation Oncology Group. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: Dummy run and individual case review. Radiother Oncol. 2009 Mar;90(3):285-290.
     
  22. Muijs CT, Beukema JC, Mul VE, Langendijk JA. In response to: Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.Letter to the editor. Accepted by Int J Radiat Oncol Biol Phys 2009Dec 1;75(5):1623.
     
  23. Muijs CT, Schreurs LM, Busz DM, Beukema JC, van der Borden AJ, Pruim J, van der Jagt EJ, Plukker JT, Langendijk JA. Consequences of additional use of PET-information for target volume delineation and radiotherapy dose distribution for esophageal cancer. Radioth Oncol 2009 Dec;93(3):447-53.
     
  24. Muntinghe FLH, Gross S, Bakker SJL, Landman GWD, van der Harst P, Bilo HJG, Navis G, Zuurman MW. CCR5 Delta 32 genotype is associated with outcome in type 2 diabetes mellitus. Diabetes Res Clin Practice 2009; 86(2): 140-145.
     
  25. Noordhuis MG, Eijsink JJH, ten Hoor KA, Hollema H, Arts HJG, Pras E, Maduro JH, Willemse PHB, de Bock GH, Wisman GBA, Schuuring E, van der Zee AGJ. Expression of EGFR and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer. Clin Cancer Res 2009 Dec 1;15(23):7389-97.
     
  26. Rinkel RN, Verdonck-de Leeuw IM, Langendijk JA, van Reij EJ, Aaronson NK, Leemans CR. The psychometric and clinical validity of the SWAL-QOL questionnairein evaluating swallowing problems experienced by patients with oral andoropharyngeal cancer. Oral Oncol. 2009 Aug;45(8):e67-71.
     
  27. Schrijvers ML, van Riel EL, Langendijk JA, Dikkers FG, Schuuring E, van der Wal JE, A M van der Laan BF. Higher laryngeal preservation rate after CO(2) laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma. Head Neck. 2009 Jun;31(6):759-64.
     
  28. van de Water TA, Bijl HP, Westerlaan HE, Langendijk JA.Delineation guidelines of organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radioth Oncol 2009  Dec;93(3):545-52.
     
  29. van Goethem MJ, van der Meer R, Reist HW, Schippers JM. Geant4 simulations of proton beam transport through a carbon or beryllium degrader and following a beam line. Phys Med Biol 2009; 54(19): 5831-5846.
     
  30. van Luijk P, Faber H, Schippers JM, Brandenburg S, Langendijk JA, Meertens HH, Coppes RP. Bath and shower effects in the parotid gland explain increase relative risk of the rat parotid gland dysfunction after IMRT. Int J Radiat Oncol Biol Phys 2009 Jul 15;74(4):1002-5.
     
  31. Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA. Intensity-Modulated Radiotherapy Reduces Radiation-Induced Morbidity and Improves Health-Related Quality of Life: Results of a Nonrandomized Prospective Study Using a Standardized Follow-Up Program. Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8.
     
  32. Vissink A, Raghoebar GM, Roodenburg JL, Reintsema H, Spijkervet FK, Witjes MJ, Schoen PJ, Bouma J, Burlage FR, Langendijk JA. Does hyperbaric oxygen therapy improve quality of life?Int J Oral Maxillofac Surg. 2009 Jan;38(1):99-100; author reply 100.
     
  33. Wedman J, Pruim J, Langendijk JA, van der Laan BF. Visualization of small glottic laryngeal cancer using methyl-labeled (11)C-methionine positron emission tomography. Oral Oncol. 2009 Aug;45(8):703-5.
     
  34. Woodward WA, Bristow RG, Clarke MF, Coppes RP, Cristofanilli M, Duda DG, Fike JR, Hambardzumyan D, Hill RP, Jordan CT, Milas L, Pajonk F, Curran WJ, Dicker AP, Chen Y. Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials. Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1580-91.
     
  35. Langendijk JA, Widder J, Sijtsema NM, van’t Veld AA.The increasing importance of advanced imaging techniques in relation to the clinical introduction of new developments in radiation oncology. Nederlands Tijdschrijft voor Nucleaire Geneeskunde 2009; 31(4): 377-389.
     
  36. Braam PR,Burlage FR.Speekselklierfunctie bij radiotherapie in het hoofd- halsgebied. Nederlands Tijdschrift voor Oncologie 2009; 8: 356-364.
     
  37. Langendijk JA, Bijl HP. Late radiation-induced side effects. In: Functional Preservation and Quality of Life in Head and Neck Radiotherapy. Harrari PM, Connor NP and Grau C, eds. Springer-Verlag Berlin Heidelberg 2009. ISBN: 978-3-540-73231 

Publicaties 2008

  1. Brouwer J, de Bree R, Comans EF, Akarriou M, Langendijk JA, Castelijns JA, Hoekstra OS, René Leemans C. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method. Radiother Oncol. 2008; 87(2): 217-20.
     
  2. Burlage FR, Roesink JM, Faber H, Vissink A, Langendijk JA, Kampinga HH, Coppes RP. Optimum dose range for the amelioration of long term radiation-induced hyposalivation using prophylactic pilocarpine treatment.Radiother Oncol. 2008;86(3):347-53.
     
  3. Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study. Int J Radiat Oncol Biol Phys. 2008;70(1):14-22.
     
  4. de Graeff P, Crijns AP, Ten Hoor KA, Klip HG, Hollema H, Oien K, Bartlett JM, Wisman GB, de Bock GH, de Vries EG, de Jong S, van der Zee AG. The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. Br J Cancer. 2008 Jul 22;99(2):341-9.
     
  5. de Jong WK, de Jonge MJ, van der Leest AH, van Meerbeeck JP, Groen HJ. Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients patients with limited-disease small-cell lung cancer: A phase I study. Lung Cancer. 2008; 61(1):123-8.
     
  6. Deganello A, Gallo O, De Cesare JM, Burali G, Gitti G, Mani R, Langendijk JA, de' Campora E. Surgical management of surgery and radiation induced peristomal neck ulcerations. B-ENT. 2008;4(3):169-74.
     
  7. Fehrmann RS, de Jonge HJ, Ter Elst A, de Vries A, Crijns AG, Weidenaar AC, Gerbens F, de Jong S, van der Zee AG, de Vries EG, Kamps WA, Hofstra RM, Te Meerman GJ, de Bont ES. A new perspective on transcriptional system regulation (TSR): towards TSR profiling. PLoS ONE. 2008 Feb 20;3(2):e1656.
     
  8. Feng J, Coppes RP. Can we rescue salivary gland function after irradiation? ScientificWorldJournal. 2008 Oct 3;8:959-62.
     
  9. Gazendam-Donofrio SM, Hoekstra HJ, van der Graaf WT, Pras E, Visser A, Huizinga GA, Hoekstra-Weebers JE. Quality of life of parents with children living at home: when one parent has cancer. Support Care Cancer. 2008;16(2):133-41.
     
  10. Genden EM, Ferlito A, Rinaldo A, Silver CE, Fagan JJ, Suárez C, Langendijk JA, Lefebvre JL, Bradley PJ, Leemans CR, Chen AY, Jose J, Wolf GT. Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck. 2008;30(1):103-10.
     
  11. Hoven-Gondrie ML, Thijssens KM, Geertzen JH, Pras E, van Ginkel RJ, Hoekstra HJ. Isolated Limb Perfusion and External Beam Radiotherapy for Soft Tissue Sarcomas of the Extremity: Long-Term Effects on Normal Tissue According to the LENT-SOMA Scoring System.Ann Surg Oncol. 2008: 15(5): 1502-10.
     
  12. Karimian G, Mohammadi-Karakani A, Sotoudeh M, Ghazi-Khansari M, Ghobadi G, Shakiba B. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats. Biomed Pharmacother. 2008 Jun;62(5):312-6. (IF: 1.418).
     
  13. Karliczek A, Zeebregts CJ, Benaron DA, Coppes RP, Wiggers T, van Dam GM. Preoperative irradiation with 5 x 5 Gy in a murine isolated colon loop model does not cause anastomotic weakening after colon resection.Int J Colorectal Dis. 2008 Jul 16.
     
  14. Langendijk JA, Doornaert P, Verdonck-de Leeuw I, Leemans CR, Aaronson NK, Slotman BJ. The impact of late treatment-related toxicity on quality of life (EORTC QLQ-C30) among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008; 26 (22): 3770-6.
     
  15. Ljumanovic R, Langendijk JA, Hoekstra OS, Knol DL, Leemans CR, Castelijns JA. Pre- and post-radiotherapy MRI results as a predictive model for response in laryngeal carcinoma. Eur Radiol. 2008 May 20.
     
  16. Lombaert IM, Brunsting JF, Wierenga PK, Faber H, Stokman MA, Kok T, Visser WH, Kampinga HH, de Haan G, Coppes RP. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS ONE. 2008 Apr 30;3(4): e2063.
     
  17. Lombaert IM, Brunsting JF, Wierenga PK, Kampinga HH, de Haan G, Coppes RP. Cytokine treatment improves parenchymal and vascular damage of salivary glands after irradiation.Clin Cancer Res. 2008 Dec 1;14(23):7741-50. (IF: 6.250).
     
  18. Lombaert IM, Brunsting JF, Wierenga PK, Kampinga HH, De Haan G, Coppes RP. Keratinocyte Growth Factor Prevents Radiation Damage to Salivary Glands by Expansion of the Stem/Progenitor Pool. Stem Cells. 2008 Jul 31.
     
  19. Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S. Targeting Pro-Apoptotic TRAIL Receptors Sensitizes HeLa Cervical Cancer Cells to Irradiation-Induced Apoptosis. Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):543-52.
     
  20. Mandl RC, Schnack HG, Zwiers MP, van der Schaaf A, Kahn RS, Hulshoff Pol HE. Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. PLoS ONE. 2008;3(11):e3631.
     
  21. Matzinger O, Poortmans P, Giraud JY, Maingon P, Budiharto T, van den Bergh AC, Davis JB, Musat E, Ataman F, Huyskens DP, Gulyban A, Bolla M; for the EORTC Radiation Oncology Group. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: Dummy run and individual case review. Radiother Oncol. 2008 Nov 27. (IF: 4.074).
     
  22. Niemantsverdriet M, Backendorf C. TwinGFP, a marker for cell cycle analysis in transiently transfected cells. Anal Biochem. 2008;375(2):173-8.
     
  23. Niemantsverdriet M, Wagner K, Visser M, Backendorf C. Cellular functions of 14-3-3zeta in apoptosis and cell adhesion emphasize its oncogenic character. Oncogene. 2008 Feb 21;27(9):1315-9.
     
  24. Schoen PJ, Raghoebar GM, Bouma J, Reintsema H, Burlage FR, Roodenburg JL, Vissink A. Prosthodontic rehabilitation of oral function in head-neck cancer patients with dental implants placed simultaneously during ablative tumour surgery: an assessment of treatment outcomes and quality of life. Int J Oral Maxillofac Surg. 2008;37(1):8-16.
     
  25. Schrijvers ML, van der Laan BFAM, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE. Overexpression of the intrinsic hypoxia markers HIF1a and CA-IX predict local recurrence in T1/T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2008 Sep 1;72(1):161-9.
     
  26. Terhaard CH, van der Schroeff MP, van Schie K, Eerenstein SE, Lubsen H, Kaanders JH, Smeele LE, Burlage FR, van Den Ende PL, Baatenburg de Jong RJ. The prognostic role of comorbidity in salivary gland carcinoma.Cancer. 2008 Aug 14;113(7):1572-1579.
     
  27. Vale C, Tierney JF, Stewart LA, Brady M, Dinshaw K, Jakobsen A, Parmar MK, Thomas G, Trimble T, Alberts DS, Chen H, Cikaric S, Eifel PJ, Garipagaoglu M, Keys H, Kantardzic N, Lal P, Lanciano R, Leborgne F, Lorvidhaya V, Onishi H, Pearcey RG, Pras E, Roberts K, Rose PG, Thomas G, Whitney CW. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008 Dec 10;26(35):5802-12. Review. (IF: 15.484).
     
  28. van der Laan HP, Dolsma WV, Maduro JH, Korevaar EW, Langendijk JA. Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapy. Radiat Oncol. 2008 Jan 31;3(1):6
     
  29. van der Laan HP, van den Bergh A, Schilstra C, Vlasman R, Meertens H, Langendijk JA. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1138-45.
     
  30. van der Putten L, Hoekstra OS, de Bree R, Kuik DJ, Comans EF, Langendijk JA, Leemans CR. 2-deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.Mol Imaging Biol. 2008 Sep;10(5):294-303.
     
  31. van Luijk P, Schippers JM. We need to bridge the gap between current practice in mathematical modeling and new insights obtained from radiobiology: comment on Zhou et al. [Med. Phys. 34, 2807-2815 (2007)] Med Phys. 2008; 35(6): 2558-9.
     
  32. Widder J, Kastenberger R, Fercher E, Schmid R, Langendijk JA, Dobrowsky W, Pötter R. Radiation dose associated with local control in advanced anal cancer: Retrospective analysis of 129 patients. Radiother Oncol. 2008; 87(3): 367-75.

Publicaties 2007

  1. Poortmans P, Bossi A, Vandeputte K, Bosset M, Miralbell R, Maingon P, Boehmer D, Budiharto T, Symon Z, van den Bergh AC, Scrase C, Van Poppel H, Bolla M; EORTC Radiation Oncology Group. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol. 2007;84(2):121-7.
     
  2. van Beek AP, van den Bergh AC, van den Berg LM, van den Berg G, Keers JC, Langendijk JA, Wolffenbuttel BH. Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma. Int J Radiat Oncol Biol Phys. 2007;68(4):986-91.
     
  3. Sijtsema NM, van den Bergh AC, Burlage FR, Bijl HP, Langendijk JA, Meertens H. Patient position verification with oblique radiation beams. Radiother Oncol. 2007 [Epub ahead of print]
     
  4. van den Bergh AC, van den Berg G, Schoorl MA, Sluiter WJ, van der Vliet AM, Hoving EW, Szabo BG, Langendijk JA, Wolffenbuttel BH, Dullaart RP. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys. 2007;67(3):863-9.
     
  5. Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A. Protection of Salivary Function by Concomitant Pilocarpine During Radiotherapy: A Double-Blind, Randomized, Placebo-Controlled Study. Int J Radiat Oncol Biol Phys. 2007; [Epub ahead of print].
     
  6. Schoen PJ, Raghoebar GM, Bouma J, Reintsema H, Burlage FR, Roodenburg JL,Vissink A. Prosthodontic rehabilitation of oral function in head-neck cancer patients with dental implants placed simultaneously during ablative tumour surgery: an assessment of treatment outcomes and quality of life. Int J Oral Maxillofac Surg. 2007; [Epub ahead of print].
     
  7. van der Laan HP, Dolsma WV, Maduro JH, Korevaar EW, Hollander M, Langendijk JA. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy.Int J Radiat Oncol Biol Phys. 2007;68(4):1018-23.
     
  8. van der Laan HP, van den Bergh A, Schilstra C, Vlasman R, Meertens H, Langendijk JA. Grading-System-Dependent Volume Effects for Late Radiation-Induced Rectal Toxicity after Curative Radiotherapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2007; [Epub ahead of print].
     
  9. Genden EM, Ferlito A, Rinaldo A, Silver CE, Fagan JJ, Suarez C, Langendijk JA, Lefebvre JL, Bradley PJ, Leemans CR, Chen AY, Jose J, Wolf GT. Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck. 2007; [Epub ahead of print].
     
  10. van Luijk P, Faber H, Meertens H, Schippers JM, Langendijk JA, Brandenburg S, Kampinga HH, Coppes RP. The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys. 2007;69(2):552-9.
     
  11. Langendijk JA. New developments in radiotherapy of head and neck cancer: Higher precision with less patient discomfort? Radiother Oncol. 2007; [Epub ahead of print].
     
  12. Ljumanovic R, Pouwels PJ, Langendijk JA, Knol DL, van der Valk P, Leemans CR, Castelijns JA. Has the degree of contrast enhancement with MR imaging in laryngeal carcinoma added value to anatomic parameters regarding prediction of response to radiation therapy?AJNR Am J Neuroradiol. 2007;28(8):1540-6.
     
  13. Poorter RL, de Bree R, Leemans CR, van der Valk P, Slotman BJ, Langendijk JA. Re-irradiation of a second localization of idiopathic midline destructive disease in the head and neck area. Eur Arch Otorhinolaryngol. 2007; [Epub ahead of print].
     
  14. Ljumanovic R, Langendijk JA, van Wattingen M, Schenk B, Knol DL, Leemans CR, Castelijns JA. MR imaging predictors of local control of glottic squamous cell carcinoma treated with radiation alone.Radiology. 2007;244(1):205-12.
     
  15. Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69(3):751-60.
     
  16. Van Gogh CD, Mahieu HF, Kuik DJ, Rinkel RN, Langendijk JA, Verdonck-de Leeuw IM. Voice in early glottic cancer compared to benign voice pathology. Eur Arch Otorhinolaryngol. 2007;264(9):1033-8.
     
  17. Jonkman A, Kaanders JH, Terhaard CH, Hoebers FJ, van den Ende PL, Wijers OB, Verhoef LC, de Jong MA, Leemans CR, Langendijk JA. Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(1):119-25.
     
  18. Langendijk JA, Bourhis J. Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr Opin Oncol. 2007;19(3):202-9.
     
  19. Leon X, Lopez M, Pineiro Z, Langendijk JA, Leemans CR, Quer M. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy. Head Neck. 2007;29(9):815-21.
     
  20. Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva. Radiother Oncol. 2007.
     
  21. Lo Galbo AM, de Bree R, Kuik DJ, Lips PT, Mary B, Von Blomberg E, Langendijk JA, Leemans CR. The prevalence of hypothyroidism after treatment for laryngeal and hypopharyngeal carcinomas: are autoantibodies of influence?Acta Otolaryngol. 2007;127(3):312-7.
     
  22. Molling JW, Langius JA, Langendijk JA, Leemans CR, Bontkes HJ, van der Vliet HJ, von Blomberg BM, Scheper RJ, van den Eertwegh AJ. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol. 2007;25(7):862-8.
     
  23. Borggreven PA, Aaronson NK, Verdonck-de Leeuw IM, Muller MJ, Heiligers ML, Bree RD, Langendijk JA, Leemans CR. Quality of life after surgical treatment for oral and oropharyngeal cancer: A prospective longitudinal assessment of patients reconstructed by a microvascular flap.Oral Oncol. 2007;43(10):1034-42.
     
  24. Borggreven PA, Leeuw IV, Rinkel RN, Langendijk JA, Roos JC, David EF, de Bree R, Leemans CR. Swallowing after major surgery of the oral cavity or oropharynx: A prospective and longitudinal assessment of patients treated by microvascular soft tissue reconstruction. Head Neck. 2007;29(7):638-47.
     
  25. Goor KM, Peeters AJ, Mahieu HF, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM, van Agthoven M. Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life, and voice quality. Head Neck. 2007;29(2):128-36.
     
  26. Gazendam-Donofrio SM, Hoekstra HJ, van der Graaf WT, Pras E, Visser A, Huizinga GA, Hoekstra-Weebers JE. Quality of life of parents with children living at home: when one parent has cancer. Support Care Cancer. 2007; [Epub ahead of print].
     
  27. van Ginkel RJ, Thijssens KM, Pras E, van der Graaf WT, Suurmeijer AJ, Hoekstra HJ. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation. Ann Surg Oncol. 2007;14(4):1499-506.
     
  28. Widder J. Post hoc, ergo propter hoc. In regard to Fietkau et al. (Int J Radiat Oncol Biol Phys 2007;67:1008-1019). Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1581; author reply 1580-1.
     
  29. Wiegman EM, Blaese MA, Loeffler H, Coppes RP, Rodemann HP. TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFbeta-receptor I signalling. Radiother Oncol. 2007;83(3):289-95.
     
  30. Bart J, Nagengast WB, Coppes RP, Wegman TD, van der Graaf WT, Groen HJ, Vaalburg W, de Vries EG, Hendrikse NH. Irradiation of rat brain reduces P-glycoprotein expression and function. Br J Cancer. 2007;97(3):322-6.
     
  31. Novakova-Jiresova A, van Luijk P, van Goor H, Kampinga HH, Coppes RP. Changes in expression of injury after irradiation of increasing volumes in rat lung. Int J Radiat Oncol Biol Phys. 2007;67(5):1510-8.
     
  32. Niemantsverdriet M, Wagner K, Visser M, Backendorf C. Cellular functions of 14-3-3zeta in apoptosis and cell adhesion emphasize its oncogenic character. Oncogene. 2007; [Epub ahead of print].

Publicaties 2006 

  1. Been LB, Wiggers T, Pras E. Using the greater omentum for the treatment of tissue damage after radiotherapy. Ned Tijdschr Geneeskd. 2006;150(23):1269-74.
     
  2. Bijl HP, van Luijk P, Coppes RP, Schippers JM, Konings AW, van der Kogel AJ. Influence of adjacent low-dose fields on tolerance to high doses of protons in rat cervical spinal cord. Int J Radiat Oncol Biol Phys. 2006;64(4):1204-10.
     
  3. Bradley PJ, Ferlito A, Suarez C, Werner JA, Genden EM, Shaha AR, Leemans CR, Langendijk JA, Rinaldo A. Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol. 2006;263(10):889-94. Review.
     
  4. Bradley PJ, Rinaldo A, Suarez C, Shaha AR, Leemans CR, Langendijk JA, Patel SG, Ferlito A. Primary treatment of the anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol. 2006;263(10):879-88. Review.
     
  5. de Boer J, Jager PL, Wiggers T, Nieboer P, Machteld Wymenga AN, Pras E, Hoogenberg K, Sleijfer DT, Suurmeijer AJ, van der Graaf WT. The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient. Int J Clin Oncol. 2006;11(6):478-81.
     
  6. de Bree R, van der Valk P, Kuik DJ, van Diest PJ, Doornaert P, Buter J, Eerenstein SE, Langendijk JA, van der Waal I, Leemans CR. Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience. Oral Oncol. 2006;42(7):703-9.
     
  7. Enting RH, van der Graaf WT, Kros JM, Heesters M, Metzemaekers J, den Dunnen W. Radiotherapy plus concomitant and adjuvant temozolomide for leptomeningeal pilomyxoid astrocytoma: a case study. J Neurooncol. 2006;80(1):107-8.
     
  8. Hougardy BM, Maduro JH, van der Zee AG, de Groot DJ, van den Heuvel FA, de Vries EG, de Jong S. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis. Int J Cancer. 2006;118(8):1892-900.
     
  9. Jellema AP, Slotman BJ, Muller MJ, Leemans CR, Smeele LE, Hoekman K, Aaronson NK, Langendijk JA. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer.Cancer. 2006;107(3):544-53.
     
  10. Kasperts N, Slotman BJ, Leemans CR, de Bree R, Doornaert P, Langendijk JA. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma. Cancer. 2006;106(7):1536-47.
     
  11. Konings AW, Faber H, Cotteleer F, Vissink A, Coppes RP. Secondary radiation damage as the main cause for unexpected volume effects: a histopathologic study of the parotid gland. Int J Radiat Oncol Biol Phys. 2006;64(1):98-105.
     
  12. Langendijk JA, Kasperts N, Leemans CR, Doornaert P, Slotman BJ. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol. 2006;78(3):306-12.
     
  13. Ljumanovic R, Langendijk JA, Hoekstra OS, Leemans CR, Castelijns JA. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging. Eur J Radiol. 2006;60(1):58-66.
     
  14. Ljungkvist AS, Bussink J, Kaanders JH, Wiedenmann NE, Vlasman R, van der Kogel AJ. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model. Radiat Res. 2006;165(3):326-36.
     
  15. Lombaert IM, Wierenga PK, Kok T, Kampinga HH, deHaan G, Coppes RP. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clin Cancer Res. 2006;12(6):1804-12.
     
  16. Nijhuis ER, van der Zee AG, in 't Hout BA, Boomgaard JJ, de Hullu JA, Pras E, Hollema H, Aalders JG, Nijman HW, Willemse PH, Mourits MJ. Gynaecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery. Int J Radiat Oncol Biol Phys. 2006;66(3):699-705.
     
  17. Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol. 2006;32(2):148-52.
     
  18. Smid EJ, Stoter TR, Bloemena E, Lafleur MV, Leemans CR, van der Waal I, Slotman BJ, Langendijk JA. The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2006;65(5):1323-9.
     
  19. Thijssens KM, van Ginkel RJ, Pras E, Suurmeijer AJ, Hoekstra HJ. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy. Ann Surg Oncol. 2006;13(4):518-24.
     
  20. van Agthoven M, Heule-Dieleman HA, Knegt PP, Kaanders JH, Baatenburg de Jong RJ, Kremer B, Leemans CR, Marres HA, Manni JJ, Langendijk JA, Levendag PC, Tjho-Heslinga RE, de Jong JM, de Boer MF, Uyl-de Groot CA. Compliance and efficiency before and after implementation of a clinical practice guideline for laryngeal carcinomas.Eur Arch Otorhinolaryngol. 2006;263(8):729-37.
     
  21. van de Pol SM, Doornaert PA, de Bree R, Leemans CR, Slotman BJ, Langendijk JA. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy.Oral Oncol. 2006;42(2):131-8.
     
  22. van der Putten L, de Bree R, Plukker JT, Langendijk JA, Smits C, Burlage FR, Leemans CR. Permanent unilateral hearing loss after radiotherapy for parotid gland tumors. Head Neck. 2006;28(10):902-8.
     
  23. van Gogh CD, Verdonck-de Leeuw IM, Boon-Kamma BA, Rinkel RN, de Bruin MD, Langendijk JA, Kuik DJ, Mahieu HF. The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer. 2006;106(1):95-105.
     
  24. van Luijk P, Novakova-Jiresova A, Faber H, Steneker MN, Kampinga HH, Meertens H, Coppes RP. Relation between radiation-induced whole lung functional loss and regional structural changes in partial irradiated rat lung. Int J Radiat Oncol Biol Phys. 2006;64(5):1495-502.
     
  25. Vergeer MR, Doornaert P, Leemans CR, Buter J, Slotman BJ, Langendijk JA. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol. 2006;79(1):39-44.
     
  26. Vieira SC, Bolt RA, Dirkx ML, Visser AG, Heijmen BJ Fast, daily linac verification for segmented IMRT using electronic portal imaging. Radiother Oncol. 2006;80(1):86-92.
     
  27. Voglmayr E, Widder J. Who makes decisions--the dilemma of decision-making within the framework of job-sharing in a hospital. Wien Med Wochenschr. 2006;156(9-10):314-7.

Publicaties 2005

  1. Bastiaannet E, Beukema JC, Hoekstra HJ. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev. 2005;31(1):18-26.
     
  2. Bijl HP, van Luijk P, Coppes RP, Schippers JM, Konings AW, van der Kogel AJ. Regional differences in radiosensitivity across the rat cervical spinal cord. Int J Radiat Oncol Biol Phys. 2005;61(2):543-51.
     
  3. Borggreven PA, Kuik DJ, Langendijk JA, Doornaert P, de Bree R, Leemans CR. Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascular reconstruction. Oral Oncol. 2005;41(4):358-64.
     
  4. Borggreven PA, Verdonck-de Leeuw I, Langendijk JA, Doornaert P, Koster MN, de Bree R, Leemans CR. Speech outcome after surgical treatment for oral and oropharyngeal cancer: a longitudinal assessment of patients reconstructed by a microvascular flap. Head Neck. 2005;27(9):785-93.
     
  5. Briet JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, ten Hoor KA, Pras E, Boezen HM, van der Zee AG, Nijman HW. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol. 2005;96(3):799-804.
     
  6. Brouwer J, Bree R, Hoekstra OS, Langendijk JA, Castelijns JA, Leemans CR. Screening for distant metastases in patients with head and neck cancer: what is the current clinical practice?Clin Otolaryngol. 2005;30(5):438-43.
     
  7. Brouwer J, de Bree R, Hoekstra OS, Golding RP, Langendijk JA, Castelijns JA, Leemans CR. Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient?Laryngoscope. 2005;115(10):1813-7.
     
  8. Buis DR, Lagerwaard FJ, Barkhof F, Dirven CM, Lycklama GJ, Meijer OW, van den Berg R, Langendijk HA, Slotman BJ, Vandertop WP. Stereotactic radiosurgery for brain AVMs: role of interobserver variation in target definition on digital subtraction angiography. Int J Radiat Oncol Biol Phys. 2005;62(1):246-52.
     
  9. Burlage FR, Pijpe J, Coppes RP, Hemels ME, Meertens H, Canrinus A, Vissink A. Variability of flow rate when collecting stimulated human parotid saliva. Eur J Oral Sci. 2005;113(5):386-90.
     
  10. Coppes RP, Meter A, Latumalea SP, Roffel AF, Kampinga HH. Defects in muscarinic receptor-coupled signal transduction in isolated parotid gland cells after in vivo irradiation: evidence for a non-DNA target of radiation. Br J Cancer. 2005;92(3):539-46.
     
  11. de Hullu JA, Pras E, Hollema H, van der Zee AG, Bogchelman DH, Mourits MJ. Presentations of endometrial activity after curative radiotherapy for cervical cancer. Maturitas. 2005;51(2):172-6.
     
  12. Hageman J, Eggen BJ, Rozema T, Damman K, Kampinga HH, Coppes RP. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.Clin Cancer Res. 2005;11(16):5956-64.
     
  13. Hougardy BM, Maduro JH, van der Zee AG, Willemse PH, de Jong S, de Vries EG. Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.Lancet Oncol. 2005;6(8):589-98.
     
  14. Jellema AP, Doornaert P, Slotman BJ, Leemans CR, Langendijk JA. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?Radiother Oncol. 2005;77(2):164-71.
     
  15. Jutte PC, van Altena R, Pras E, Thijn CJ. Causes of misdiagnosis and mistreatment of spinal tuberculosis with radiotherapy in nonendemic areas: a pitfall in diagnosis and treatment: hazards of radiotherapy on the tuberculous lesion. Spine. 2005;30(11):E300-4.
     
  16. Kasperts N, Slotman B, Leemans CR, Langendijk JA. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol. 2005;41(3):225-43.
     
  17. Konings AW, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys. 2005;62(4):1187-94.
     
  18. Konings AW, Cotteleer F, Faber H, van Luijk P, Meertens H, Coppes RP. Volume effects and region-dependent radiosensitivity of the parotid gland. Int J Radiat Oncol Biol Phys. 2005;62(4):1090-5.
     
  19. Konings AW, Faber H, Cotteleer F, Vissink A, Coppes RP. Secondary radiation damage as the main cause for unexpected volume effects: a histopathologic study of the parotid gland. Int J Radiat Oncol Biol Phys. 2006;64(1):98-105.
     
  20. Konings AW, Faber H, Vissink A, Coppes RP. Radioprotective effect of amifostine on parotid gland functioning is region dependent. Int J Radiat Oncol Biol Phys. 2005;63(5):1584-91.
     
  21. Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer. 2005;104(7):1408-17.
     
  22. Molling JW, Kolgen W, van der Vliet HJ, Boomsma MF, Kruizenga H, Smorenburg CH, Molenkamp BG, Langendijk JA, Leemans CR, von Blomberg BM, Scheper RJ, van den Eertwegh AJ. Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int J Cancer. 2005;116(1):87-93.
     
  23. Novakova-Jiresova A, van Luijk P, van Goor H, Kampinga HH, Coppes RP. Pulmonary radiation injury: identification of risk factors associated with regional hypersensitivity. Cancer Res. 2005;65(9):3568-76.
     
  24. Reerink O, Mulder NH, Verschueren RC, Wiggers T, Szabo BG, Hospers GA. Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase I study. Anticancer Res. 2005;25(1B):629-33.
     
  25. Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. J Clin Oncol. 2005;23(7):1455-62.
     
  26. Schaapveld M, de Vries EG, Otter R, de Vries J, Dolsma WV, Willemse PH. Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy. Br J Cancer. 2005;93(5):520-8.
     
  27. Stokman MA, Spijkervet FK, Burlage FR, Roodenburg JL. Clinical effects of flurbiprofen tooth patch on radiation-induced oral mucositis. A pilot study. Support Care Cancer. 2005;13(1):42-8.
     
  28. Terhaard CH, Lubsen H, Rasch CR, Levendag PC, Kaanders HH, Tjho-Heslinga RE, van Den Ende PL, Burlage F; Dutch Head and Neck Oncology Cooperative Group. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys. 2005;61(1):103-11.
     
  29. Thijssens KM, van Ginkel RJ, Suurmeijer AJ, Pras E, van der Graaf WT, Hollander M, Hoekstra HJ. Radiation-induced sarcoma: a challenge for the surgeon. Ann Surg Oncol. 2005;12(3):237-45.
     
  30. van Agthoven M, Heule-Dieleman HA, de Boer MF, Kaanders JH, Baatenburg de Jong RJ, Kremer B, Leemans CR, Marres HA, Manni JJ, Langendijk JA, Levendag PC, Tjho-Heslinga RE, de Jong JM, Uyl-de Groot CA, Knegt PP. Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas. Radiother Oncol. 2005;74(3):337-44.
     
  31. van de Pol SM, Doornaert PA, de Bree R, Leemans CR, Slotman BJ, Langendijk JA. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy.Oral Oncol. 2006;42(2):131-8.
     
  32. van der Laan HP, Dolsma WV, van 't Veld AA, Bijl HP, Langendijk JA. Comparison of normal tissue dose with three-dimensional conformal techniques for breast cancer irradiation including the internal mammary nodes. Int J Radiat Oncol Biol Phys. 2005;63(5):1522-30.
     
  33. van Gogh CD, Verdonck-de Leeuw IM, Boon-Kamma BA, Langendijk JA, Kuik DJ, Mahieu HF. A screening questionnaire for voice problems after treatment of early glottic cancer. Int J Radiat Oncol Biol Phys. 2005;62(3):700-5.
     
  34. van Luijk P, Bijl HP, Konings AW, van der Kogel AJ, Schippers JM. Data on dose-volume effects in the rat spinal cord do not support existing NTCP models. Int J Radiat Oncol Biol Phys. 2005;61(3):892-900.
     
  35. van Luijk P, Novakova-Jiresova A, Faber H, Schippers JM, Kampinga HH, Meertens H, Coppes RP. Radiation damage to the heart enhances early radiation-induced lung function loss. Cancer Res. 2005;65(15):6509-11.
     
  36. Visser A, Huizinga GA, Hoekstra HJ, van der Graaf WT, Klip EC, Pras E, Hoekstra-Weebers JE. Emotional and behavioural functioning of children of a parent diagnosed with cancer: a cross-informant perspective. Psychooncology. 2005;14(9):746-58.
     
  37. Widder J, Herbst F, Dobrowsky W, Schmid R, Pokrajac B, Jech B, Chiari C, Stift A, Maier A, Karner-Hanusch J, Teleky B, Wrba F, Jakesz R, Poetter R. Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II). Br J Cancer. 2005;92(7):1209-14.
     
  38. Widder J, Herbst F, Scheithauer W. Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer. Acta Oncol. 2005;44(8):921-3.
     
  39. Wiegman EM, van den Bergh AC. Diagnostic image (254). A woman with white iris spots.Ned Tijdschr Geneeskd. 2005;149(51):2861.

Publicaties 2004

  1. Aufenacker TJ, van Geldere D, van Mesdag T, Bossers AN, Dekker B, Scheijde E, van Nieuwenhuizen R, Hiemstra E, Maduro JH, Juttmann JW, Hofstede D, van Der Linden CT, Gouma DJ, Simons MP. The role of antibiotic prophylaxis in prevention of wound infection after Lichtenstein open mesh repair of primary inguinal hernia: a multicenter double-blind randomized controlled trial. Ann Surg. 2004;240(6):955-61.
     
  2. van den Bergh AC, Schoorl MA, Dullaart RP, van der Vliet AM, Szabo BG, ter Weeme CA, Pott JW. Lack of radiation optic neuropathy in 72 patients treated for pituitary adenoma. J Neuroophthalmol. 2004;24(3):200-5.
     
  3. de Boer JR, Pruim J, Albers FW, Burlage F, Vaalburg W, van der Laan BF. Prediction of survival and therapy outcome with 11C-tyrosine PET in patients with laryngeal carcinoma. J Nucl Med. 2004;45(12):2052-7.
     
  4. Brouwer J, Bodar EJ, De Bree R, Langendijk JA, Castelijns JA, Hoekstra OS, Leemans CR. Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement.Eur Arch Otorhinolaryngol. 2004;261(8):417-22.
     
  5. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, van den Bergh AC, de Winter KA, Koper PC, Lybeert ML, Slot A, Lutgens LC, Stenfert Kroese MC, Beerman H, van Lent M; postoperative Radiation Therapy in Endometrial Carcinoma Trial. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol. 2004;22(7):1234-41.
     
  6. Groen HJ, van der Leest AH, Fokkema E, Timmer PR, Nossent GD, Smit WJ, Nabers J, Hoekstra HJ, Hermans J, Otter R, van Putten JW, de Vries EG, Mulder NH. Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study.Ann Oncol. 2004;15(3):427-32.
     
  7. Kasperts N, Slotman B, Leemans CR, Langendijk JA. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol. 2005;41(3):225-43.
     
  8. Langendijk JA, Poorter R, Leemans CR, de Bree R, Doornaert P, Slotman BJ. Radiotherapy of squamous cell carcinoma of the nasal vestibule. Int J Radiat Oncol Biol Phys. 2004;59(5):1319-25.
     
  9. Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol. 2004;22(22):4604-12.
     
  10. Ljumanovic R, Langendijk JA, Schenk B, Van Wattingen M, Knol DL, Leemans CR, Castelijns JA. Supraglottic carcinoma treated with curative radiation therapy: identification of prognostic groups with MR imaging. Radiology. 2004;232(2):440-8.
     
  11. Novakova-Jiresova A, Van Gameren MM, Coppes RP, Kampinga HH, Groen HJ. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol. 2004;71(2):183-9.
     
  12. Peeters AJ, van Gogh CD, Goor KM, Verdonck-de Leeuw IM, Langendijk JA, Mahieu HF. Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol. 2004;261(10):534-40.
     
  13. Reerink O, Mulder NH, Szabo BG, Sluiter WJ, Wiggers T, Bongaerts AH, Hospers GA. Developments in treatment of primary irresectable rectal cancer. Colorectal Dis. 2004;6(6):406-17.
     
  14. Reerink O, Mulder NH, Botke G, Sluiter WJ, Szabo BG, Plukker JT, Verschueren RC, Hospers GA. Treatment of locally recurrent rectal cancer, results and prognostic factors. Eur J Surg Oncol. 2004;30(9):954-8.
     
  15. Reerink O, Mulder NH, Szabo BG, Hospers GA. 5FU and oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patients. Anticancer Res. 2004;24(3b):1969-71.
     
  16. Reerink O, Karrenbeld A, Plukker JT, Verschueren RC, Szabo BG, Sluiter WJ, Hospers GA, Mulder NH. Molecular prognostic factors in locally irresectable rectal cancer treated preoperatively by chemo-radiotherapy. Anticancer Res. 2004;24(2C):1217-21.
     
  17. Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol. 2004;11(11):1018-24.
     
  18. Slotman BJ, van der Wal G, Kregar S, Langendijk JA, Willems DL. Patients' appreciation of single fraction radiotherapy for painful bone metastases. Palliat Med. 2004;18(1):72-3.
     
  19. Stiegelis HE, Hagedoorn M, Sanderman R, Bennenbroek FT, Buunk BP, van den Bergh AC, Botke G, Ranchor AV. The impact of an informational self-management intervention on the association between control and illness uncertainty before and psychological distress after radiotherapy. Psychooncology. 2004;13(4):248-59.
     
  20. Stokman MA, Spijkervet FK, Burlage FR, Roodenburg JL. Clinical effects of flurbiprofen tooth patch on radiation-induced oral mucositis. A pilot study. Support Care Cancer. 2005;13(1):42-8.
     
  21. de Vos FY, Bos AM, Gietema JA, Pras E, Van der Zee AG, de Vries EG, Willemse PH. Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer. Anticancer Res. 2004;24(1):345-8.
     
  22. Wiegman EM, van Gameren MM, Kampinga HH, Szabo BG, Coppes RP. Post-irradiation dietary vitamin E does not affect the development of radiation-induced lung damage in rats. Radiother Oncol. 2004;72(1):67-70.